| Literature DB >> 27984785 |
Amanda L Collar1, Elizabeth C Clarke1, Eduardo Anaya2, Denise Merrill1, Sarah Yarborough3, Scott M Anthony4, Jens H Kuhn5, Christine Merle6, Manfred Theisen6, Steven B Bradfute7.
Abstract
Ebolaviruses are emerging pathogens that cause severe and often fatal viral hemorrhagic fevers. Four distinct ebolaviruses are known to cause Ebola virus disease in humans. The ebolavirus envelope glycoprotein (GP1,2) is heavily glycosylated, but the precise glycosylation patterns of ebolaviruses are largely unknown. Here we demonstrate that approximately 50 different N-glycan structures are present in GP1,2 derived from the four pathogenic ebolaviruses, including high mannose, hybrid, and bi-, tri-, and tetra-antennary complex glycans with and without fucose and sialic acid. The overall N-glycan composition is similar between the different ebolavirus GP1,2s. In contrast, the amount and type of O-glycan structures varies widely between ebolavirus GP1,2s. Notably, this O-glycan dissimilarity is also present between two variants of Ebola virus, the original Yambuku variant and the Makona variant responsible for the most recent Western African epidemic. The data presented here should serve as the foundation for future ebolaviral entry and immunogenicity studies.Entities:
Keywords: Bundibugyo virus; Ebola virus; Ebolavirus; Filoviridae; Filovirus; Glycan; Glycoprotein; Glycosylation; Sudan virus; Taï Forest virus
Mesh:
Substances:
Year: 2016 PMID: 27984785 DOI: 10.1016/j.virol.2016.12.010
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616